Warren Buffett portfolio

Berkshire Hathaway · 13F for Q2 2026, filed Aug 14, 2026

Berkshire Hathaway, Warren Buffett's company, reported 29 positions worth $299B as of Jun 30, 2026. The largest were Apple Inc. (22.0%), American Express Co (17.1%) and Coca Cola Co (10.9%). Against Q1 2026: 1 new, 7 added to, 5 reduced, 1 sold out.

The filing on sec.gov · Every fund · What a 13F shows

Reported value
$299Bas of Jun 30
Positions
291 new, 1 sold out
Largest position
AAPL22.0% of the portfolio
Top 10 positions
88%of reported value

The stock desk, weekly · free

The week in filings, every Monday

The companies expected to report that week, the results filed the week before, and the biggest short interest moves, each linked to its page.

The stock desk, weekly: one email each Monday with the companies expected to report that week, the results filed the week before and the biggest short interest moves. Unsubscribe in one click.

What Warren Buffett bought

Largest 6 of 8
PositionChangeValue
GOOGLAlphabet Inc.+45.2%$8.8B
GOOGAlphabet Inc.+658.4%$8.3B
DALDelta Air Lines, Inc.+44.0%$1.6B
LENLennar Corp+29.8%$273M
MMacy's, Inc.+141.8%$101M
NYTNew York Times Co+3.6%$38.7M

What Warren Buffett sold

Q2 2026 against Q1 2026
PositionChangeValue
BACBank of America Corp−5.9%$1.7B
COFCapital One Financial Corp−58.0%$833M
KRKroger Co−22.0%$611M
DVADavita Inc.−4.0%$272M
STZConstellation Brands, Inc.Sold out$94.9M
ALLYALLY Financial Inc.−6.9%$91.9M

Every position, largest first

29 positions, Q2 2026
#PositionPortfolioValueSharesChange
1AAPLApple Inc.22.0%$66.0B227,917,808No change
2AXPAmerican Express Co17.1%$51.3B151,610,700No change
3KOCoca Cola Co10.9%$32.5B400,000,000No change
4GOOGLAlphabet Inc.9.41%$28.2B78,791,167+45.2%
5BACBank of America Corp9.20%$27.5B483,394,015−5.9%
6CVXChevron Corp4.67%$14.0B84,375,856No change
7OXYOccidental Petroleum Corp4.30%$12.9B264,941,431No change
8CBChubb Ltd3.90%$11.7B34,249,183No change
9MCOMoodys Corp3.73%$11.2B24,669,778No change
10GOOGAlphabet Inc.3.21%$9.6B27,188,433+658.4%
11KHCKraft Heinz Co2.57%$7.7B325,634,818No change
12DVADavita Inc.2.15%$6.4B28,880,209−4.0%
13DALDelta Air Lines, Inc.1.79%$5.4B57,320,000+44.0%
14SIRISirius Xm Holdings Inc.1.23%$3.7B124,807,117No change
15VRSNVerisign Inc0.76%$2.3B8,989,880No change
16KRKroger Co0.72%$2.2B39,000,000−22.0%
17ALLYALLY Financial Inc.0.41%$1.2B27,000,000−6.9%
18LENLennar Corp0.40%$1.2B13,111,741+29.8%
19LLYVKLiberty Live Holdings, Inc.0.37%$1.1B10,587,143No change
20NYTNew York Times Co0.37%$1.1B15,700,000+3.6%
21COFCapital One Financial Corp0.20%$602M3,000,000−58.0%
22LLYVALiberty Live Holdings, Inc.0.17%$505M4,986,588No change
23LPXLouisiana-Pacific Corp0.15%$446M5,664,793No change
24NUENucor Corp0.14%$414M1,857,752Not compared
25MMacy's, Inc.0.06%$173M7,347,426+141.8%
4 more positions
#PositionPortfolioValueSharesChange
26NVRNVR Inc0.03%$75.7M11,112No change
27LEN-BLennar Corp0.01%$26.4M298,117+25.4%
28JEFJefferies Financial Group Inc.0.01%$21.7M433,558No change
29DHIHorton D R Inc0.00%$581K3,564New

What a 13F shows

This is Berkshire Hathaway’s Form 13F for the quarter ended Jun 30, 2026, filed with the SEC on Aug 14, 2026 as Berkshire Hathaway Inc. A 13F lists long positions in US-listed securities on the quarter’s last day: shares, convertible bonds, puts and calls. It does not list short positions, cash, private holdings or most securities listed abroad, and a position may have changed since.

Options are shown as options, never added to the shares of the stock they are written on. A change is the share count against the fund's filing for Q1 2026; the estimated value of a change uses the price the filing's own figures imply. Where a count moved with a stock split, no change is shown.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.